ArticleCell death & disease2021

Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.

Yuqing Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.